Literature DB >> 23244721

Benign prostatic hyperplasia: a brief overview of pathogenesis, diagnosis, and therapy.

Ryan Priest1, Mark Garzotto, John Kaufman.   

Abstract

Benign prostatic hyperplasia is a common condition, causing symptoms in 75% of men over the age of 70. To understand the role of a novel treatment for this condition, an understanding of the pathology, approach to diagnosis, and range of existing therapies are important. This article provides a general overview of benign prostatic hyperplasia evaluation and management.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23244721     DOI: 10.1053/j.tvir.2012.10.001

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  5 in total

1.  The value of respective urodynamic parameters for evaluating the occurrence of complications linked to benign prostatic enlargement.

Authors:  Xingliang Yang; Kai Wang; Jiang Zhao; Wei Yu; Longkun Li
Journal:  Int Urol Nephrol       Date:  2014-05-09       Impact factor: 2.370

2.  Meta-analysis of vitamin D receptor gene polymorphisms and benign prostatic hyperplasia risk.

Authors:  Xian-Tao Zeng; Qi-Sheng Yao; Hong Weng; Sheng Li; Jing-Yu Huang; Xing-Huan Wang
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

3.  Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients.

Authors:  Bing-Hui Li; Tong Deng; Qiao Huang; Hao Zi; Hong Weng; Xian-Tao Zeng
Journal:  Am J Mens Health       Date:  2019 Jul-Aug

4.  Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer.

Authors:  Felix Royo; Patricia Zuñiga-Garcia; Verónica Torrano; Ana Loizaga; Pilar Sanchez-Mosquera; Aitziber Ugalde-Olano; Esperanza González; Ana R Cortazar; Laura Palomo; Sonia Fernández-Ruiz; Isabel Lacasa-Viscasillas; Maria Berdasco; James D Sutherland; Rosa Barrio; Amaia Zabala-Letona; Natalia Martín-Martín; Amaia Arruabarrena-Aristorena; Lorea Valcarcel-Jimenez; Alfredo Caro-Maldonado; Jorge Gonzalez-Tampan; Guido Cachi-Fuentes; Manel Esteller; Ana M Aransay; Miguel Unda; Juan M Falcón-Pérez; Arkaitz Carracedo
Journal:  Oncotarget       Date:  2016-02-09

5.  Herbal medicine for benign prostatic hyperplasia: A protocol for a systematic review of controlled trials.

Authors:  Ji Hwan Kim; Kyung Moo Park; Ju Ah Lee
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.